The first human who received an implant from Neuralink underwent the procedure at Barrow Neurological Institute, according to an April 12 news release from Barrow. The implant is about the size of a quarter and is placed in a person’s skull by a surgical robot.
The Neuralink PRIME Study is looking for adults with quadriplegia due to vertical spinal cord injury or ALS. These adults, according to the release, need to be at least 22 years old and have someone to help them take part in the study.
Neuralink was founded in 2017 and received FDA clearance for clinical trials in humans in May.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.